Beginning of designing an high sensitivity optical instrument capable of detecting a wider number of molecular targets than conventional systems.
NTP Nano Tech Projects s.r.l. founded in Sant'Angelo in Vado (Marche region - Italy).
Releasing of the first Nano Eye Device(NED) proof of concept for virus detection.
Italian patent application filed.
International Patent Application (PTC) filed.
Integration of ICT functionality in the Nano Eye Device.
Evolution of the Nano Eye Device into "Smart Microscope" and new application in Digital Pathology (DP).
Italian patent granted.
EU project - H2020 SMEINST Phase 1 grant ad.
Start of the Digital Pathology and Molecular Diagnostics projects.
NTP recognized as the first italian innovative startup with a social vocation.
International Patent Application (PCT) published by World Intellectual Property Organization (WIPO) in Digital Pathology.
Releasing of the first NED Digital Pathology prototype.
NTP got a substantial equity capital (seed) from the most important italian BA, Italian Angels for Growth(IAG).
Beginning of clinical validation on digital pathology at the Trento Hospital and the Humanitas Research Hospital.
Releasing of the first NED Virus Detection prototype.
Beginning of the design of the molecular diagnostics process at the University of Urbino on HPV test cases.
NTP recognized as Innovative SME.
Second investment by Italian Angels for Growth (IAG).
Investment by Trentino Sviluppo.
Opening of a second office in Rovereto (Trento - Italy).
Releasing of the second NED-VD prototype with better performance.
Patent granted in USA, Japan and Singapore.
Beginning of clinical validation of molecular diagnostics process at the University of Pavia (San Matteo) on test cases to detect high-risk HPV (HPV16), full tests on human samples.
Start of the new molecular diagnostics project for the detection of Sars-Cov2.
Patent granted in the EU.
CE-IVD certification for NED-DP obtained.
Beginning of designing an high sensitivity optical instrument capable of detecting a wider number of molecular targets than conventional systems.
NTP Nano Tech Projects s.r.l. founded in Sant'Angelo in Vado (Marche region - Italy).
Releasing of the first Nano Eye Device(NED) proof of concept for virus detection.
Italian patent application filed.
International Patent Application (PTC) filed.
Integration of ICT functionality in the Nano Eye Device.
Evolution of the Nano Eye Device into "Smart Microscope" and new application in Digital Pathology (DP).
Italian patent granted.
EU project - H2020 SMEINST Phase 1 grant ad.
Start of the Digital Pathology and Molecular Diagnostics projects.
NTP recognized as the first italian innovative startup with a social vocation.
International Patent Application (PCT) published by World Intellectual Property Organization (WIPO) in Digital Pathology.
Releasing of the first NED Digital Pathology prototype.
NTP got a substantial equity capital (seed) from the most important italian BA, Italian Angels for Growth(IAG).
Beginning of clinical validation on digital pathology at the Trento Hospital and the Humanitas Research Hospital.
Releasing of the first NED Virus Detection prototype.
Beginning of the design of the molecular diagnostics process at the University of Urbino on HPV test cases.
NTP recognized as Innovative SME.
Second investment by Italian Angels for Growth (IAG).
Investment by Trentino Sviluppo.
Opening of a second office in Rovereto (Trento - Italy).
Releasing of the second NED-VD prototype with better performance.
Patent granted in USA, Japan and Singapore.
Beginning of clinical validation of molecular diagnostics process at the University of Pavia (San Matteo) on test cases to detect high-risk HPV (HPV16), full tests on human samples.
Start of the new molecular diagnostics project for the detection of Sars-Cov2.
Patent granted in the EU.
CE-IVD certification for NED-DP obtained.
Chief Executive Officer
Chairman of the Board
Sales & Marketing Manager
Scientific Director
Chief Information Officer
Junior Software Engineer
UI/UX Junior Designer
Project Manager
Biology Specialist
Chief Technology Officer
Biology Specialist
Business Management